Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmacy topic
No spam. Unsubscribe anytime.
Dahl Memorial Clinic readies pharmacy rollout; awaits DEA number and plans phased start
Summary
The Dahl Memorial Clinic will begin filling prescriptions through a new pharmacy service once it receives its DEA number; staff reported NPI obtained and a staged rollout using Rx30 and TelePharm with training planned with pharmacists in Juneau and Kenai.
The Dahl Memorial Clinic’s executive director, Director Wall, told the board on Jan. 30 that the clinic had received its NPI number and is awaiting a DEA registration number before launching pharmacy dispensing.
The plan described to the board calls for a staged rollout: staff will test a small number of prescriptions initially (Director Wall said he expected to be among early test patients), TelePharm will be used with pharmacists in Juneau and Kenai for handoff training, and the clinic will not publicly announce full pharmacy availability until staff confirm inventory and workflows. The clinic will use Rx30 as its pharmacy management system.
Why it matters: Establishing an on-site pharmacy will allow the clinic to dispense prescriptions locally rather than sending patients off the road system, improving continuity of care in Skagway. The board emphasized a cautious rollout to avoid sudden demand surges and to ensure inventory and training are in place.
Key details from the meeting
- Director Wall reported the clinic has its NPI number; the DEA number is pending. The pharmacy cannot fill controlled substances or operate fully until DEA registration is issued.
- The rollout will be gradual: initial tests will use prescriptions already in hand, and staff will order inventory based on known prescriptions before accepting mass transfers to the clinic.
- TelePharm training will pair the clinic’s lead (Asia) with pharmacists in Juneau and Kenai to work through workflows and handoffs; Wall also plans media outreach and direct communications when the phased opening date is set.
- Wall cautioned against a broad public announcement at opening to avoid a large one-day surge of transferred prescriptions; the pharmacy will publish a clear transfer process, an 800 number and an email address for pharmacy communications.
Open items and dependencies
- DEA registration (pending) is the gating item. Staff also must complete inventory ordering and training with TelePharm and Rx30 integration.
- The board requested staff to notify the board when the DEA number is granted and to provide a timetable for the public rollout. No formal vote was necessary for the update.
Sources: Director Wall’s executive-director report and discussion during the Jan. 30 board meeting.
